Connect with us
In 2025 Poland, legal medical cannabis has clear quality, safety, and dosing advantages over unpredictable illegal street product, making therapeutic use more sensible than recreational smoking....
In 2025, medical cannabis use in Poland stabilized and matured. Pharmacies dispensed over 5 tons to 105,000 patients through 537,000 prescriptions. Growth slowed after rapid expansion...
Europe’s cannabis reputation often points to the Netherlands or Portugal, yet Malta and Luxembourg made the real breakthrough by granting a legal right to home cultivation....
On December 15, 2025, President Trump confirmed his administration is strongly considering reclassifyingcannabis from Schedule I to Schedule III. While not full legalization, the shift would...
The German cannabis industry faces regulatory and competitive turmoil. Remexian is accused by competitor Vayamed of violating licensing rules for irradiated medicinal cannabis by using group...
A new US appropriations bill effectively redefining hemp tightens THC limits, bans synthetic cannabinoids, and could dismantle much of the current hemp-derived products market. Critics call...
Seven years after legalization, Canada has collected over CAD 5.4 billion in cannabis taxes, mostly benefiting provinces—Alberta leads per capita, while Quebec lags due to restrictive...
The Swiss Hemp Association welcomes Switzerland’s draft Cannabis Act as a historic shift toward regulated, science-based legalization but urges key improvements. It argues Switzerland can outperform...
Schleswig-Holstein’s cannabis cooperatives have begun harvesting, with one distributing 13.6 kilograms to members. Three of ten associations have harvested, though two are still drying their crops....
Germany’s Federal Council backed stricter medicinal cannabis rules, prompting criticism from Bloomwell, which warns a mail-order ban would endanger patient access. The SPD is expected to...